NASDAQ:JBIO

Jade Biosciences Stock Forecast

etoro logo Buy JBIO
*Your capital is at risk
$21.73
-0.230 (-1.05%)
At Close: Aug 10, 2026

Should you buy JBIO stock?

Last updated:

Based on market data through , StockInvest.us rates Jade Biosciences, Inc. (JBIO) as a Buy Candidate with a technical score of 1.02 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 1.78%
  • 3-month trend forecast Down 2.67%
  • Buy Candidate 1.02
AI Analysis AI Analysis of JBIO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add JBIO to Watchlist?
Some Reasons Why To Add JBIO:
  • +193.6% price growth over the last year
  • Low bankruptcy risk (Altman Z-Score: 17.55)
  • +53.5% YTD performance
PDF

Red day on Monday for Jade Biosciences, Inc. stock after losing 1.05%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Aug 04, 2026 Gain 1.78%

The Jade Biosciences, Inc. stock price fell by -1.05% on the last day (Monday, 10th Aug 2026) from $21.96 to $21.73. During the last trading day the stock fluctuated 1.20% from a day low at $21.68 to a day high of $21.94. The price has fallen in 6 of the last 10 days but is still up by 8.92% over the past 2 weeks. Volume has increased on the last day by 142 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 624 thousand shares were bought and sold for approximately $13.55 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $22.30 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -2.67% during the next 3 months and, with a 90% probability hold a price between $14.17 and $21.71 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

JBIO Signals & Forecast

The Jade Biosciences, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $21.13 and $21.06. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -3.55%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Jade Biosciences, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $18.59 and $17.74. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Jade Biosciences, Inc. finds support just below today's level at $18.59. If this is broken, then the next support from accumulated volume will be at $17.74 and $16.82.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.260 between high and low, or 1.20%. For the last week, the stock has had daily average volatility of 5.98%.

Our recommended stop-loss: $21.07 (-3.05%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 23 days ago.)

Trading Expectations (JBIO) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Jade Biosciences, Inc. to open at $21.78, and during the day (based on 14 day Average True Range), to move between $21.02 and $22.44, which gives a possible trading interval of +/-$1.42 (+/-6.73%) up or down from last closing price. If Jade Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 6.73% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $21.81 (0.37%) than the support at $18.59 (14.45%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Jade Biosciences, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.024 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $21.78 ( 0.245%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

JBIO Performance

Trading levels for JBIO

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 22.04 1.44%
R2 21.94 0.98%
R1 21.88 0.703%
Price 21.73
S1 21.68 -0.212%
S2 21.62 -0.494%
S3 21.52 -0.95%

Accumulated Volume Support & Resistance Levels

Level Price
R3 22.00 1.24%
R2 21.97 1.10%
R1 21.81 0.368%
Price 21.73
S1 18.59 -14.45%
S2 17.74 -18.36%
S3 16.82 -22.60%

JBIO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 29, 2025 Apr 29, 2025 Apr 29, 2025 $2.40 23.67%

FAQ

What is the symbol for Jade Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Jade Biosciences, Inc. is JBIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Jade Biosciences, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Jade Biosciences, Inc. (JBIO) as a Buy Candidate with a technical score of 1.02 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Aug 04, 2026, the price has risen 1.78%. The current 3-month trend forecast projects a fall of 2.67%.

How to buy Jade Biosciences, Inc. Stock?
Jade Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Jade Biosciences, Inc. Stock.

What's the current price of Jade Biosciences, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Jade Biosciences, Inc. (JBIO) share was $21.73.

What is the 52-week high and low for Jade Biosciences, Inc. Stock?
The 52-week high for Jade Biosciences, Inc. Stock is $27.96 and the 52-week low is $6.67.

What is the market capitalization of Jade Biosciences, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Jade Biosciences, Inc. is 708.959M.

When is the next earnings date for Jade Biosciences, Inc.?
The upcoming earnings date for Jade Biosciences, Inc. is Aug 12, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE